Skip to main content

. 1969 Dec;32(6):555–561. doi: 10.1136/jnnp.32.6.555

Relationships between headache and amine changes after administration of reserpine to migrainous patients.

G Curzon, M Barrie, M I Wilkinson

PMCID: PMC496589 PMID: 5364727

555

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

ASHCROFT G. W., CRAWFORD T. B., BINNS J. K., MACDOUGALL E. J. ESTIMATION OF 5-HYDROXYTRYPTAMINE IN HUMAN BLOOD. Clin Chim Acta. 1964 Apr;9:364–369. doi: 10.1016/0009-8981(64)90027-0. [DOI] [PubMed] [Google Scholar]
Anthony M., Hinterberger H., Lance J. W. Plasma serotonin in migraine and stress. Arch Neurol. 1967 May;16(5):544–552. doi: 10.1001/archneur.1967.00470230096013. [DOI] [PubMed] [Google Scholar]
Campus S., Fabris F., Rappelli A., Gastaldi L., Gai V., Nattero G. Escrezione urinaria di acido 5-idrossiindolacetico durante crisi cefalalgica indotta da trinitroglicerina. Boll Soc Ital Biol Sper. 1967 Dec 31;43(24):1844–1847. [PubMed] [Google Scholar]
Curran D. A., Hinterberger H., Lance J. W. Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects. Brain. 1965 Dec;88(5):997–1010. doi: 10.1093/brain/88.5.997. [DOI] [PubMed] [Google Scholar]
Curzon G., Theaker P., Phillips B. Excretion of 5-hydroxyindolyl acetic acid (5HIAA) in migraine. J Neurol Neurosurg Psychiatry. 1966 Feb;29(1):85–90. doi: 10.1136/jnnp.29.1.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
Hinterberger H., Anthony M., Vagholkar M. K. Platelet 5-hydroxytryptamine and adenine nucleotides, serum arginylesterase and plasma 11-hydroxycorticosteroids in migraine. Clin Sci. 1968 Apr;34(2):271–276. [PubMed] [Google Scholar]
Kulkarni A. S., Shideman F. E. Sensitivities of the brains of infant and adult rats to the catecholamine-depleting actions of reserpine and tetrabenazine. J Pharmacol Exp Ther. 1966 Sep;153(3):428–433. [PubMed] [Google Scholar]
SICUTERI F. PROPHYLACTIC TREATMENT OF MIGRAINE BY MEANS OF LYSERGIC ACID DERIVATIVES. Triangle. 1963 Oct;67:116–125. [PubMed] [Google Scholar]
TODRICK A., DICK M., TAIT A. C. Effect of reserpine in therapeutic dosage on excretion of 5-hydroxyindoleacetic acid. Br Med J. 1958 Mar 1;1(5069):496–499. doi: 10.1136/bmj.1.5069.496. [DOI] [PMC free article] [PubMed] [Google Scholar]
WINSOR T. Human pharmacology of reserpine. Ann N Y Acad Sci. 1954 Apr 30;59(1):61–81. doi: 10.1111/j.1749-6632.1954.tb45919.x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES